This page is for clinic review ONLY outside of the EngagedMD platform.
Open
Close
GLT_US_SOL_1_Germline
Germline Genetic Testing
STP_US_SOL_1_Somatic
Somatic Genetic Testing
IMRT_US_SOL_1_Intro
Intensity-Modulated Radiation Therapy
IMRT_US_SOL_2_Before
Before Treatment
IMRT_US_SOL_3_During
What to Expect During Treatment
IMRT_US_SOL_4_Risks
Risks and Side Effects
IMRT_US_SOL_5_Treatment
Navigating Treatment
RSP_US_SOL_1_Intro
Rectal Spacer Placement
RSP_US_SOL_2_Risks
PCT_US_SOL_1_Team
Your Cancer Care Team
PCT_US_SOL_2_Surgical
Surgical Treatment
PCT_US_SOL_3_Radiation
Radiation Treatment
PCT_US_SOL_4_Medication
Medication Treatment
PCM_US_SOL_1_Waiting
Watchful Waiting
PAS_US_SOL_1_Surveillance
Active Surveillance
PRY_US_SOL_01_RARP
Robot-Assisted Radical Prostatectomy
PRY_US_SOL_02_Recovery
Recovery
PRY_US_SOL_03_Risks
Risks and Complications
EBRT_US_SOL_1_Radiation
What is Radiation?
EBRT_US_SOL_2_Before
EBRT_US_SOL_3_Expect
What To Expect During Radiation Therapy
EBRT_US_SOL_4_Risks
EBRT_US_SOL_5_Treatment
BIR_US_SOL_1_Brachy
What Is Brachytherapy?
BIR_US_SOL_2_Prep
Preparing for Brachytherapy
HDRP_US_SOL_1_HDR
High-Dose Rate (HDR) Brachytherapy
HDRP_US_SOL_2_Risks
LDR_US_SOL_1_LDR
Low-Dose Rate (LDR) Brachytherapy
LDR_US_SOL_2_Risks
SBRT_US_SOL_1_Intro
Stereotactic Body Radiation Therapy
SBRT_US_SOL_2_Before
SBRT_US_SOL_3_During
SBRT_US_SOL_4_Risks
SBRT_US_SOL_5_Treatment
ADT_US_SOL_1_BackgroundIntro
What Is Androgen Deprivation Therapy?
ADT_US_SOL_2_PrescriptionMedication
ADT Medications
ADT_US_SOL_3_Risks&Recovery
FMP_US_SOL_1_Procedure
Fiducial Marker Placement
FMP_US_SOL_2_Risks
Recovery and Risks
HIF_US_SOL_1_HIFU
High-Intensity Focused Ultrasound (HIFU)
HIF_US_SOL_2_Procedure
The Procedure
HIF_US_SOL_3_Recovery
HIF_US_SOL_4_Risks
HIF_US_SOL_5_Monitoring
Follow-Up Monitoring
AUC_US_SOL_1_About
Specialized Care for Advanced Prostate Cancer
APC_US_SOL_1_Options
Treatment Options for Advanced Prostate Cancer
IAP_US_SOL_1_Imaging
Imaging for Advanced Prostate Cancer
BHS_US_SOL_1_About
Supporting Bone Health During Prostate Cancer Treatment
PAR_US_SOL_1_Intro
PARP Inhibitors
PAR_US_SOL_2_Risks
IPC_US_SOL_1_Intro
Checkpoint Inhibitor Immunotherapy
IPC_US_SOL_2_Risks
Checkpoint Inhibitors: What to Expect
